Phase 1b/2a Subcutaneous Formulation (Obesity) Published: The Lancet, June 2025 Participants: 125 adults with overweight or obesity (BMI 27.039.9), aged 1855 Duration: Up to 36 weeks Dosing: Once-weekly subcutaneous amycretin, up to 60 mg Results: - Up to 22% absolute weight loss at 36 weeks (highest dose group) - Placebo-adjusted difference: approximately 24% - No weight-loss plateau observed at study end Safety: 81% of the 89 participants who reported a TEAE had gastrointestinal events
However, it is crucial to understand the limited evidence available due to the relatively new treatments offered, and their use should be approached with caution, considering potential side effects
This study looked at the patients pain tolerance at tender points as well as pain intensity, pressure pain threshold, muscle strength, and static muscle endurance
Therefore, the primary purpose of this study was to determine the effects of an 8-week RT program in conjunction with daily, orally-delivered GSH + L-citrulline, L-citrulline-malate, or placebo supplementation on body composition and muscle performance
Do I need to do anything special before my laser appointment
The same goes for mixing salicylic or glycolic acid with other strong exfoliating ingredients like lactic acid or retinoids
